NCT01105975
A Study of LY2484595 in Patients With High LDL-C or Low HDL-C
See it on ClinicalTrials.gov ↗393 people
56%
44%
220 womenmiddle line = equal numbers173 men
- Phase
- PHASE2
- Paid for by
- Eli Lilly and Company
- Finished
- 2011-06
- Health conditions
- Dyslipidemia
- Who could join
- Anyone
- Ages
- 18 Years – no maximum
- Average age
- mean 58.3 years
- Age 65+
- Not reported
- Weight (BMI)
- mean 29.0 kilogram/square meter (kg/m²)
- Pregnancy recorded
- Not reported
- Menopause recorded
- Not reported
- Results shown by sex
- Not split by sex
- Race
- White 92.9% · Black / African American 5.1% · More than one race 1.8% · Asian 0.3% · American Indian / Alaska Native 0% · Native Hawaiian / Pacific Islander 0% · Not reported 0%
Women left out
- No pregnant women
Women who were pregnant could not join.
“Breastfeeding woman or a woman who can still become pregnant, but are not willing to use a valid birth control measure to prevent pregnancies”
- No breastfeeding moms
Women who were breastfeeding could not join.
“Breastfeeding woman or a woman who can still become pregnant, but are not willing to use a valid birth control measure to prevent pregnancies”
- Had to use birth control
Women who couldn't or didn't want to use birth control were turned away.
“Breastfeeding woman or a woman who can still become pregnant, but are not willing to use a valid birth control measure to prevent pregnancies”
- No heart disease
Women with heart disease, heart rhythm problems or a past heart attack were turned away.
“History of coronary heart disease, or hardening of the arteries, or heart does not pump sufficiently well”
- No cancer
Women with current or past cancer were turned away.
“Have disease of liver, kidneys, muscles or other organs of body, a serious infection or cancer, or abnormal laboratory tests that study physician does not consider compatible with participation in the study”
Study titles and rules are shown in their original English.